ezetimibe
0 sources
ezetimibe
Summary
ezetimibe is a type of chemical entity[1]. ezetimibe has Wikipedia articles in 22 language editions, a strong signal of global cultural recognition.[2]
Key Facts
- ezetimibe's instance of is recorded as type of chemical entity[3].
- ezetimibe's physically interacts with is recorded as NPC1 like intracellular cholesterol transporter 1[4].
- ezetimibe's canonical SMILES is recorded as C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O[5].
- ezetimibe's chemical formula is recorded as C₂₄H₂₁F₂NO₃[6].
- ezetimibe is a type of (3R,4S)-1-(4-fluorophenyl)-3-[3-(4-fluorophenyl)-3-hydroxypropyl]-4-(4-hydroxyphenyl)-2-azetidinone[7].
- ezetimibe is used for medication[8].
- ezetimibe's Commons category is recorded as Ezetimibe[9].
- ezetimibe's route of administration is recorded as oral administration[10].
- ezetimibe's significant drug interaction is recorded as fenofibrate[11].
- ezetimibe's isomeric SMILES is recorded as C1=CC(=CC=C1[C@@H]2C@HCCC@@HO)OC@HCCC@@HO)O">[12].
- ezetimibe's mass is recorded as {'unit': 'Q483261', 'amount': '+409.14895'}[13].
- ezetimibe's medical condition treated is recorded as familial hypercholesterolemia[14].
- ezetimibe's medical condition treated is recorded as familial hypercholesterolemia[15].
- ezetimibe's medical condition treated is recorded as lipedema[16].
- ezetimibe's medical condition treated is recorded as rare dyslipidemia[17].
- ezetimibe's World Health Organisation international non-proprietary name is recorded as {'lang': 'en', 'text': 'ezetimibe'}[18].
- ezetimibe's subject has role is recorded as anticholesteremic agents[19].
- ezetimibe's subject has role is recorded as lipid regulating agents[20].
- ezetimibe's pregnancy category is recorded as Australian pregnancy category C[21].
- ezetimibe's pregnancy category is recorded as US pregnancy category C[22].
- ezetimibe's legal status is recorded as boxed warning[23].
Why It Matters
ezetimibe has Wikipedia articles in 22 language editions, a strong signal of global cultural recognition.[2]